Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Chinese Human Vaccine-focused Biotech Firm Gets $36M In Series A Round – China Money Network
Venture Capital

Chinese Human Vaccine-focused Biotech Firm Gets $36M In Series A Round – China Money Network

by chinamoneynetwork.com posted 1week ago 16 views
Chinese biotechnology firm Zhongyianke Biotech announced on Thursday that it has raised RMB250 million (US$36.35 million) in a series A round of financing from a group of investors including Chinese investment firm Shenzhen Qianhai Beizeng Asset Management.